Optimind TMS Treatment Centres is a health care startup focusing on repetitive Transcranial Magnetic Stimulation (rTMS) and cognitive training. The company's slogan, "Repetitive Transcranial Magnetic Stimulation and Cognitive Training in a beautiful, calm, and welcoming clinic setting," reflects its commitment to a peaceful and supportive environment for patients. Optimind's primary treatment, rTMS, is approved by Health Canada and is known for its safety and effectiveness in treating conditions such as depression, anxiety, PTSD, and OCD, as well as age-related memory decline.
The team at Optimind boasts extensive medical and technical expertise, including specialized training in noninvasive neural stimulation at Harvard Medical School, Canada’s largest mental health teaching hospital’s Temerty Centre for Therapeutic Brain Intervention at CAMH, and with International Clinical TMS Certification through the University of Maastricht.
As an innovative and compassionate player in the health care and health and wellness industries, Optimind's approach is persistent and focused on improving lives. The company is positioned as an expert in rTMS and emphasizes their dedication to helping individuals "Just. Feel. Better." While details such as the company's founding date, headquarters, and last investment are not specified, the company's focus on leveraging advanced medical techniques and its commitment to improving mental health make it an intriguing potential investment opportunity for venture capitalists.
There is no investment information
No recent news or press coverage available for Optimind TMS Treatment Centres.